InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GHT | Ann: Removal from Official List at close 13 Janua | 12/01/12 | 0 | 247 | |||
|
|||||||
GHT | Ann: Results of Meeting | 08/12/11 | 0 | 184 | |||
|
|||||||
GHT | Ann: Change of Director's Interest Notice | 05/12/11 | 0 | 184 | |||
|
|||||||
GHT | Ann: Suspension from Official Quotation (close 6/ | 02/12/11 | 0 | 178 | |||
|
|||||||
GHT | Ann: Cancellation of Unlisted Options | 02/12/11 | 0 | 179 | |||
|
|||||||
GHT +HAV | Ann: Compulsory Acquisition of Outstanding GHT Sh | 01/12/11 | 1 | 296 | |||
|
|||||||
GHT | Ann: Quarterly Activities and Cashflow Reports | 30/11/11 | 0 | 148 | |||
|
|||||||
GHT | Ann: Final Director's Interest Notice | 29/11/11 | 0 | 146 | |||
|
See All Discussions